methylphenidate (Ritalin) might be carcinogenic
February 1996
There are new concerns that methylphenidate (Ritalin) might be carcinogenic.
Ciba is putting new info in the package insert...and sending out a letter to physicians and pharmacists.
This is based on recent toxicology studies which show an increased incidence of liver tumours in some mice...but not in rats.
Upgrade now to access this resource
This content is not available under the subscriptions purchased by your organization, but you can add it on!
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive